Hypofractionated Radiotherapy Concomitantly With Weekly Boost for Breast Cancer Patients Treated With Conservative Breast Surgery

Retrospective Study Evaluating Hypofractionated Radiotherapy Concomitantly With Weekly Boost for Breast Cancer Patients Treated With Conservative Breast Surgery

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04815642

Enrollment

Registered

2021-03-25

Start date

2021-12-01

Completion date

2023-04-01

Last updated

2021-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Brief summary

This is a retrospective study on evaluation of the efficacy and the safety of a hypofractionated radiotherapy course with weekly concomitant boost for breast cancer patients treated with conservative breast surgery .

Interventions

RADIATIONradiotherapy

Hypofractionated radiotherapy concomitantly with weekly boost

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 75 Years

Healthy volunteers

Yes

Inclusion criteria

1. women aged from 18 and up to 55 years old. 2. Histologically diagnosed with breast carcinoma (ductal and others ) 3. All patients with conservative breast surgery. 4. Including all patients with in all stages except those stage IV. 5. All patients with clear free surgical margin. 6. patients received hypofractionated radiotherapy with weekly concomitant boost

Exclusion criteria

1. Evidence of distant metastatic deposites. 2. patients with mastectomy 3. patients with prior irradiation to thoracic region. 4. pregnancy or lactation.

Design outcomes

Primary

Measure	Time frame	Description
Disease free survival	baseline	Disease Free survival

Contacts

Primary ContactNada Mohamed shawky, Master degree

nadanada2008916@gmail.com+201021985279

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026